Combining angiotensin-receptor blockers with angiotensin-converting-enzyme inhibitors
- PMID: 21422130
- PMCID: PMC3071405
- DOI: 10.1503/cmaj.110366
Combining angiotensin-receptor blockers with angiotensin-converting-enzyme inhibitors
Erratum in
- CMAJ. 2011 Jun 14;183(9):1054
Comment on
-
The safety of combining angiotensin-converting-enzyme inhibitors with angiotensin-receptor blockers in elderly patients: a population-based longitudinal analysis.CMAJ. 2011 Apr 5;183(6):655-62. doi: 10.1503/cmaj.101333. Epub 2011 Mar 21. CMAJ. 2011. PMID: 21422125 Free PMC article.
Similar articles
-
COVID-19 and inhibitors of the renin-angiotensin-aldosterone system.Expert Rev Anti Infect Ther. 2021 Jul;19(7):815-816. doi: 10.1080/14787210.2021.1851197. Epub 2020 Nov 26. Expert Rev Anti Infect Ther. 2021. PMID: 33198546 Free PMC article. No abstract available.
-
The safety of combining angiotensin-converting-enzyme inhibitors with angiotensin-receptor blockers in elderly patients: a population-based longitudinal analysis.CMAJ. 2011 Apr 5;183(6):655-62. doi: 10.1503/cmaj.101333. Epub 2011 Mar 21. CMAJ. 2011. PMID: 21422125 Free PMC article.
-
Risk of Sepsis and Mortality Among Patients With Chronic Obstructive Pulmonary Disease Treated With Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Blockers.Crit Care Med. 2019 Jan;47(1):e14-e20. doi: 10.1097/CCM.0000000000003475. Crit Care Med. 2019. PMID: 30303835
-
Beta-blockers, calcium channel blockers, angiotensin converting enzyme inhibitors and angiotensin receptor blockers: should they be stopped or not before ambulatory anaesthesia?Curr Opin Anaesthesiol. 2010 Dec;23(6):687-90. doi: 10.1097/ACO.0b013e32833eeb19. Curr Opin Anaesthesiol. 2010. PMID: 20805745 Review.
-
Evaluating for seasonal variation in angiotensin-converting enzyme inhibitor- and angiotensin receptor blocker-induced angioedema.Ann Allergy Asthma Immunol. 2014 Feb;112(2):178-9. doi: 10.1016/j.anai.2013.11.016. Epub 2013 Dec 12. Ann Allergy Asthma Immunol. 2014. PMID: 24468261 Review. No abstract available.
References
-
- Gibbons GH, Dzau VJ. The emerging concept of vascular remodeling. N Engl J Med 1994;330:1431–8 - PubMed
-
- Hunt SA, Abraham WT, Chin MH, et al. 2009 focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation 2009;119:e391–479 - PubMed
-
- Heart Failure Society of America, Lindenfeld J, Albert NM, Boehmer JP, et al. HFSA 2010 comprehensive heart failure practice guideline. J Card Fail 2010;16:e1–194 - PubMed
-
- O’Hare AM, Kaufman JS, Covinsky KE, et al. Current guidelines for using angiotensin-converting enzyme inhibitors and angiotensin II–receptor antagonists in chronic kidney disease: Is the evidence base relevant to older adults? Ann Intern Med 2009;150:717–24 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources